Bone Health in Adults with Type 1 Diabetes
成人 1 型糖尿病患者的骨骼健康
基本信息
- 批准号:10228685
- 负责人:
- 金额:$ 36.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-13 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:20 year oldAcuteAddressAdultAdvanced Glycosylation End ProductsAffectAgeAreaBody mass indexBone DensityBone ResorptionBone TissueBone structureCaringChronicClinical TrialsClosure by clampDiabetes MellitusDiagnosisElderlyElementsFemurFinancial HardshipFutureGenderGeometryHip FracturesHip region structureHyperglycemiaHypoglycemiaImpairmentInsulinInsulin-Dependent Diabetes MellitusInterventionIntervention TrialKnowledgeLong-Term EffectsMeasuresMechanicsMorbidity - disease rateOsteoporosisPatientsPhenotypePopulationPrevention approachPropertyProspective cohort studyResearchResearch Project GrantsRiskRoentgen RaysRoleTestingThickTimeVertebral columnWorkX-Ray Computed Tomographybasebonebone fragilitybone healthbone massbone qualitybone strengthbone turnovercohortcoronary artery calcificationepidemiology studyfracture riskglycemic controlhigh riskimprovedin vivoindexinginsulin dependent diabetes mellitus onsetmortalitynon-diabeticrisk prediction modelskeletaltibia
项目摘要
Abstract
People with type 1 diabetes (T1D) have a six- to eight-fold higher risk for hip fractures compared to people
without diabetes. Hip fractures are associated with significant morbidity, mortality, loss of independence, and
financial burden. Moreover, hip fracture mortality is higher in patients with diabetes compared to subjects
without diabetes.
Dual x-ray absorptiometry (DXA), the most common test to assess bone health, underestimates fracture risk in
patients with T1D. Altered geometry in young-onset T1D (T1D diagnosis before age 20), and reduced bone
mechanical and material qualities are implicated in bone fragility in T1D. Chronic hyper- and hypoglycemia is
postulated to suppress bone turnover leading to accumulation of microdamage and advanced glycation
endproducts (AGE) resulting in compromised bone material properties in T1D. Despite higher fracture risk, the
effect of T1D on bone structural and material properties and diabetes-related factors affecting bone health are
unknown.
Considering the knowledge gap, we propose to evaluate baseline skeletal phenotype using validated
quantitative computed tomography (QCT), finite element (FE) based bone strength, and OsteoProbe®-
measured in vivo bone material strength index (BMSi), and changes in these measures over 3 years in a large
cohort of adults with and without T1D from the ongoing ‘Coronary Artery Calcification in Type 1 Diabetes’
(CACTI) study. We will also determine the role of acute hyper- and hypoglycemia on bone turnover and its
long-term impact on bone material properties.
With improved care, people with T1D are living longer and there is no specific approach for prevention and
treatment of osteoporosis for older adults with T1D. Therefore, this research project will help to characterize
bone phenotype and the effect of long-term hyperglycemia on bone changes over a period of three years; and
therefore, it will allow for future clinical trials to improve bone health and reduce facture risk among adults with
T1D.
抽象的
与人相比
没有糖尿病。髋部骨折与明显的发病率,死亡率,独立丧失以及
财务负担。此外,糖尿病患者与受试者相比,髋部骨折死亡率更高
没有糖尿病。
双X射线绝对肽仪(DXA)是评估骨骼健康的最常见测试,低估了骨折风险
T1D患者。年轻T1D的几何形状改变(20岁之前的T1D诊断),骨骼减少
T1D中的骨骼脆弱性暗示了机械和材料质量。慢性高血糖症是
假定是为了抑制骨转换,导致微塑料和晚期糖基的积累
最终产物(年龄)导致T1D中的骨骼材料特性受损。尽管骨折风险更高,但
T1D对影响骨骼健康的骨结构和材料特性以及与糖尿病有关的因素的影响是
未知。
考虑到知识差距,我们建议使用经过验证的基线骨骼表型评估基线骨骼表型
定量计算机断层扫描(QCT),有限元(Fe)骨强度和Osteopobe®-
在体内骨材料强度指数(BMSI)中测量,并在3年内进行这些测量的变化
来自有或没有T1D的成年人的队列来自正在进行的“ 1型糖尿病中的冠状动脉钙化”
(仙人掌)研究。我们还将确定急性高血糖和低血糖对骨转换及其的作用
长期对骨骼材料特性的影响。
随着护理的改善,患有T1D的人的寿命更长,没有特定的预防方法和
治疗T1D老年人的骨质疏松症。因此,该研究项目将有助于表征
骨表型和长期高血糖对骨骼变化的影响在三年内;和
因此,这将允许将来的临床试验改善骨骼健康,并降低
T1D。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Viral N Shah其他文献
Viral N Shah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Viral N Shah', 18)}}的其他基金
Volumetric bone density, geometry, strength and bone tissue material properties in type 1 diabetes
1 型糖尿病的体积骨密度、几何形状、强度和骨组织材料特性
- 批准号:
9918247 - 财政年份:2019
- 资助金额:
$ 36.55万 - 项目类别:
Volumetric bone density, geometry, strength and bone tissue material properties in type 1 diabetes
1 型糖尿病的体积骨密度、几何形状、强度和骨组织材料特性
- 批准号:
10376142 - 财政年份:2019
- 资助金额:
$ 36.55万 - 项目类别:
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Integrating Epidemiologic and Genomic Data to Elucidate the Genetic Overlap Between Congenital Anomalies and Pediatric Cancer
整合流行病学和基因组数据来阐明先天性异常和儿童癌症之间的遗传重叠
- 批准号:
10749761 - 财政年份:2023
- 资助金额:
$ 36.55万 - 项目类别:
Exploring the Impact of Genetic Ancestry on Acute Lymphoblastic Leukemia Risk in Latino Populations
探索遗传血统对拉丁裔人群急性淋巴细胞白血病风险的影响
- 批准号:
10607300 - 财政年份:2023
- 资助金额:
$ 36.55万 - 项目类别:
Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia
高血压干预减少急性淋巴细胞白血病儿童骨坏死
- 批准号:
10356868 - 财政年份:2020
- 资助金额:
$ 36.55万 - 项目类别:
Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia
高血压干预减少急性淋巴细胞白血病儿童骨坏死
- 批准号:
10591587 - 财政年份:2020
- 资助金额:
$ 36.55万 - 项目类别: